The weekly litigation news digest is live. Subscribe now

Outlook Therapeutics competitive analysis

Explore Outlook Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 25, 2025
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Outlook Therapeutics

Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody Composition1

Latest PTAB cases involving Outlook Therapeutics

Discover the latest PTAB cases involving Outlook Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Outlook Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OUTLOOK THERAPEUTICS - 1 - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - -